What are the guidelines for Pap (Papanicolau) smears for cervical cancer screening in women of different ages and risk factors?

Guidelines for Pap Smear Screening

Women aged 21-29 years should undergo Pap testing every 3 years, while women aged 30-65 years should preferably receive HPV co-testing with Pap test every 5 years (or Pap test alone every 3 years as an acceptable alternative). 1, 2

---

Age-Specific Screening Recommendations

Women Under Age 21

• Do not screen women under age 21, regardless of sexual activity or age of sexual debut. 1, 3
• Screening this population provides no benefit and leads to unnecessary procedures and anxiety. 3

Women Aged 21-29 Years

• Screen with Pap test alone every 3 years after an initial normal result. 4, 1, 2
• Do NOT use HPV testing in this age group for routine screening or management of abnormal results. 4, 2
• HPV infections are extremely common and typically transient in younger women, making HPV testing inappropriate and leading to overtreatment. 4

Women Aged 30-65 Years

• Preferred approach: HPV co-testing (Pap test plus HPV DNA test) every 5 years. 4, 1, 2
• Acceptable alternative: Pap test alone every 3 years. 4, 1, 3
• The 5-year interval with co-testing is supported by the increased sensitivity of the combined approach for detecting high-grade precancerous lesions. 2, 3
• Evidence shows that screening every 1-2 years compared to every 3 years improves effectiveness by less than 5%, making more frequent screening inefficient. 1, 2

Women Over Age 65

• Discontinue screening if adequate prior screening with normal results has been documented. 1, 5, 3
• Adequate prior screening is defined as either:
  • 3 consecutive negative Pap tests within the past 10 years, with the most recent test within 5 years 5, 3
  • OR 2 consecutive negative HPV and Pap co-tests within the past 10 years, with the most recent test within 5 years 4, 5
• Once screening is discontinued, it should not resume for any reason, even if a woman reports having a new sexual partner. 5

---

Special Populations Requiring Modified Screening

Women Who Have Had a Hysterectomy

• Discontinue screening if the cervix was removed and there is no history of high-grade precancerous lesions (CIN2+) or cervical cancer. 4, 1, 3
• Continue screening for at least 20-25 years after treatment if hysterectomy was performed for cervical cancer or high-grade lesions, even past age 65. 2, 5

High-Risk Women Requiring More Frequent Screening

• Women with the following risk factors may require continued screening beyond age 65 and/or more frequent intervals: 1, 5
  • History of CIN2, CIN3, or adenocarcinoma in situ (continue screening for at least 20 years after treatment) 5
  • HIV infection or immunocompromised status 2, 5
  • History of cervical cancer 2
  • In utero diethylstilbestrol (DES) exposure 2
  • Multiple sexual partners 5

Women Who Have Never Been Screened

• Regardless of age, women who have never been screened should receive at least 2 negative Pap smears 1 year apart. 1, 5
• Never-screened women have an incidence of cervical cancer 3-4 times higher than women with at least one prior normal Pap smear. 5

---

Critical Documentation and Patient Communication

Documentation Requirements

• Provide women with written documentation stating whether a Pap test was obtained during their visit. 4, 2
• Self-reports of Pap test completion are often inaccurate and require clinical record verification. 4, 2
• When available, provide a copy of the Pap test result to the patient. 4

Patient Education Points

• Discuss the purpose and importance of Pap testing at each visit where pelvic examination is performed. 4
• Many women erroneously believe a Pap test was performed when only a pelvic examination occurred—clarify this distinction. 4
• Explain that HPV vaccination does not change screening recommendations; vaccinated women should be screened identically to unvaccinated women. 4

---

Common Pitfalls to Avoid

Over-Screening

• Annual Pap testing is NOT recommended and increases costs and potential harms without significantly improving cancer detection. 1, 6
• Despite guidelines, 55% of American women report annual screening, which is excessive. 7
• The decline in screening frequency from 2000-2015 represents appropriate movement toward evidence-based intervals. 6, 8

Under-Screening High-Risk Populations

• Do not discontinue screening prematurely in women with previous abnormal results, immunocompromised status, or HIV infection. 1, 5
• An estimated 14 million women aged 21-65 have not been screened within the past 3 years, representing a significant gap. 8
• Recent immigrants, uninsured women, and women without a usual source of healthcare have lower screening rates and require targeted outreach. 8

Inappropriate Screening After Hysterectomy

• Screening after hysterectomy with cervix removal for benign reasons is unnecessary and wasteful. 1, 3
• However, verify that the cervix was actually removed, as some women undergo supracervical hysterectomy. 5

Screening the Very Elderly

• Despite recommendations, 38% of women aged 75-84 and 20% of women aged 85+ report annual Pap smears, which is inappropriate. 7
• For women over 65 with adequate prior screening, the absolute benefit in life-years gained from continued screening is extremely small. 5

---

Medicare Coverage

• Medicare covers Pap testing and pelvic examinations at 3-year intervals for average-risk women. 2, 5
• Yearly screening is allowed for women at high risk of cervical or vaginal cancer or those with an abnormal Pap smear in the preceding 3 years. 2, 5